Today in News History

On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1917, The Bisbee Deportation occurs as vigilantes kidnap and deport nearly 1,300 striking miners and others from Bisbee, Arizona. In 1928, Elias James Corey, American chemist and academic, Nobel Prize laureate was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1948, Ben Burtt, American director, screenwriter, and sound designer was born. In 1982, Jason Wright, American football player, businessman, and executive was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 1992, Luke Berry, English footballer was born. Together, these milestones provide historical context for today's news news and ongoing narratives.

Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet

The Eastern Herald

The Eastern Herald

·

July 8, 2026

·

center

Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing

Narrative Intelligence Brief

This article was published by The Eastern Herald, a source frequently categorized with a center bias based in India. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Eastern Herald, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

5 sources

Left 20%

Center 20%

Right 60%


The Motley Fool

lean left

· Jul 10, 2026

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?

Additional blockbuster drugs may be on the horizon.

The Eastern Herald

center

· Jun 26, 2026

Cancer Patients Swapping Chemotherapy for Ivermectin as Oncologists Sound Alarm

A JAMA Network Open study tracking 68 million patient records found ivermectin prescriptions among cancer patients more than doubled after Mel Gibson's Joe Rogan interview. The American Society of Clinical Oncology says there is no clinical evidence the antiparasitic drug treats cancer and that its interactions with chemotherapy remain incompletely understood.

Seeking Alpha

lean right

· Jun 22, 2026

AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition

AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition

Proto Thema - English

lean right

· Jul 3, 2026

Doctors and pharmacists ran fake prescription racket, with damages above €400,000

The ringleader has been arrested, while another nine people are named in the case file, including a psychiatrist and a doctor at a public hospital. More than 5,400 fake prescriptions have been identified The post Doctors and pharmacists ran fake prescription racket, with damages above 400,000 appeared first on ProtoThema English.

The Hindu BusinessLine

lean right

· Jun 23, 2026

IT selloff drags Nifty below 24,000; pharma stocks buck the trend

Pharma bucked the broader trend and remained the standout performer of the session. Cipla led gains on the Nifty 50, rising 2.56 per cent to 1,452 with over 37.20 lakh shares traded worth 53,831.39 lakh

Topics:

Business · 3
World · 2

Related coverage for "Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet": The Motley Fool — Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?. The Eastern Herald — Cancer Patients Swapping Chemotherapy for Ivermectin as Oncologists Sound Alarm. Seeking Alpha — AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition. Proto Thema - English — Doctors and pharmacists ran fake prescription racket, with damages above €400,000. The Hindu BusinessLine — IT selloff drags Nifty below 24,000; pharma stocks buck the trend